What does Fournier Thomas MedGen do?

Fournier Thomas MedGen is a general practice in Eghezée. Private Limited, started on 5 January 2022, 2 establishments.

What is the address of Fournier Thomas MedGen?

The registered office of Fournier Thomas MedGen is located at Rue de la Croix d'Or,Upigny 6, 5310 Eghezée.

Is Fournier Thomas MedGen still active?

Yes. According to the CBE (29 September 2026) Fournier Thomas MedGen is active, legal situation “Normale toestand”, started on 5 January 2022.

Is Fournier Thomas MedGen registered on Peppol?

Yes, Fournier Thomas MedGen is registered on the Peppol network with ID 0208:0779703321.

What is the enterprise number of Fournier Thomas MedGen?

The enterprise number of Fournier Thomas MedGen is BE0779703321.

When was Fournier Thomas MedGen founded?

Fournier Thomas MedGen was founded on 5 January 2022.

Is Fournier Thomas MedGen a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 5 January 2022; 4 annual accounts filed, latest fiscal year 2025; 2 establishments in the CBE.

How much profit did Fournier Thomas MedGen make in 2025?

Fournier Thomas MedGen posted a profit after taxes of € 68,295 in financial year 2025.

What is the revenue of Fournier Thomas MedGen?

As a small company, Fournier Thomas MedGen is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 101,545.

Fournier Thomas MedGen (Private Limited) - Eghezée

Dossier Fournier Thomas MedGen, printed on 29 September 2026 from databakkes.be/en/0779703321/fournier-thomas-medgen. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Fournier Thomas MedGen from Eghezée, company number BE0779703321, closed financial year 2025 with a result of € 68,295 after tax. For that financial year Fournier Thomas MedGen recorded a gross margin of € 101,545 and equity of € 2,000. Compared with financial year 2024, the result moved from € 58,820 to € 68,295. Profitable, and profit is growing. The buffer shrank hard: equity is 99 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 27, 2026.

What it is worth Shrank hard

€ 2,000

▼ 99% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 68,295

▲ 16% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 163,180

▲ 18% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 224,486 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 13,951

▼ 40% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 5,894

▼ 39% vs 2024

€ 3,892 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 127

▼ 16% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 56,850 Gross margin 2022: € 56,850 First fiscal year in the series	€ 97,090 Gross margin 2023: € 97,090 ▲ 71% vs 2022 (€ 56,850) Favourable step	€ 91,453 Gross margin 2024: € 91,453 ▼ 6% vs 2023 (€ 97,090) Unfavourable step	€ 101,545 Gross margin 2025: € 101,545 ▲ 11% vs 2024 (€ 91,453) Favourable step	▲ 11%
Profit after taxes	€ 41,124 Profit after taxes 2022: € 41,124 First fiscal year in the series	€ 57,846 Profit after taxes 2023: € 57,846 ▲ 41% vs 2022 (€ 41,124) Favourable step	€ 58,820 Profit after taxes 2024: € 58,820 ▲ 2% vs 2023 (€ 57,846) Favourable step	€ 68,295 Profit after taxes 2025: € 68,295 ▲ 16% vs 2024 (€ 58,820) Favourable step	▲ 16%
Equity	€ 42,324 Equity 2022: € 42,324 First fiscal year in the series	€ 99,370 Equity 2023: € 99,370 ▲ 135% vs 2022 (€ 42,324) Favourable step	€ 158,190 Equity 2024: € 158,190 ▲ 59% vs 2023 (€ 99,370) Favourable step	€ 2,000 Equity 2025: € 2,000 ▼ 99% vs 2024 (€ 158,190) Unfavourable step	▼ 99%
Total debts	€ 31,505 Total debts 2022: € 31,505 First fiscal year in the series	€ 25,659 Total debts 2023: € 25,659 ▼ 19% vs 2022 (€ 31,505) Favourable step	€ 46,769 Total debts 2024: € 46,769 ▲ 82% vs 2023 (€ 25,659) Unfavourable step	€ 220,566 Total debts 2025: € 220,566 ▲ € 173,797 vs 2024 (€ 46,769) Unfavourable step	▲ € 173,797
Cash	€ 26,732 Cash 2022: € 26,732 First fiscal year in the series	€ 81,626 Cash 2023: € 81,626 ▲ 205% vs 2022 (€ 26,732) Favourable step	€ 137,932 Cash 2024: € 137,932 ▲ 69% vs 2023 (€ 81,626) Favourable step	€ 163,180 Cash 2025: € 163,180 ▲ 18% vs 2024 (€ 137,932) Favourable step	▲ 18%
Retained profit	€ 40,324 Retained profit 2022: € 40,324 First fiscal year in the series	€ 97,370 Retained profit 2023: € 97,370 ▲ 141% vs 2022 (€ 40,324) Favourable step	€ 156,190 Retained profit 2024: € 156,190 ▲ 60% vs 2023 (€ 97,370) Favourable step	€ 0 Retained profit 2025: € 0 ▼ 100% vs 2024 (€ 156,190) Unfavourable step	▼ 100%
Dividend	€ 800 Dividend 2022: € 800 First fiscal year in the series	€ 800 Dividend 2023: € 800 Unchanged (€ 800) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 800) Unchanged	€ 224,486 Dividend 2025: € 224,486 Unchanged (€ 0) Unchanged
Bank debt	€ 18,479 Bank debt 2022: € 18,479 First fiscal year in the series	€ 13,247 Bank debt 2023: € 13,247 ▼ 28% vs 2022 (€ 18,479) Favourable step	€ 9,641 Bank debt 2024: € 9,641 ▼ 27% vs 2023 (€ 13,247) Favourable step	€ 5,894 Bank debt 2025: € 5,894 ▼ 39% vs 2024 (€ 9,641) Favourable step	▼ 39%
Balance sheet total	€ 73,829 Balance sheet total 2022: € 73,829 First fiscal year in the series	€ 125,029 Balance sheet total 2023: € 125,029 ▲ 69% vs 2022 (€ 73,829) Unchanged	€ 204,960 Balance sheet total 2024: € 204,960 ▲ 64% vs 2023 (€ 125,029) Unchanged	€ 222,566 Balance sheet total 2025: € 222,566 ▲ 9% vs 2024 (€ 204,960) Unchanged	▲ 9%

Key figures of Fournier Thomas MedGen, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Fournier Thomas MedGen?

What happened at Fournier Thomas MedGen in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 27, 2026 New annual accounts for financial year 2025: profit of € 68,295 (▲ 16% vs 2024). filed late Source: NBB ↗
Jan 5, 2022 New establishment in La Bruyère. KBO
Jan 5, 2022 New establishment in Eghezée. KBO
Jan 5, 2022 Start of the company according to the CBE. KBO

In short

From € 41,124 profit in 2022 to € 68,295 profit in 2025.

Paid € 70,184 in corporate taxes since 2022.

Best year ever: 2025, with € 68,295 profit.

Paid out € 226,086 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Fournier Thomas MedGen? We notify you, reason included.

Follow Fournier Thomas MedGen

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de la Croix d'Or,Upigny 6

5310 Eghezée

2.326.346.743

Chaussée d'Eghezée, Meux 52 box A

5081 La Bruyère

Active since 5 January 2022

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0779.703.321
VAT number: BE 0779.703.321
Registered office: Rue de la Croix d'Or,Upigny 6, 5310 Eghezée
Names & denominations: Fournier Thomas MedGen
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 5 January 2022
Peppol: Active · Active since 10 Dec 2025
Activities · NACE: Activiteiten van huisartspraktijken

View on CBE Public ↗ Annual accounts (NBB) ↗

Fournier Thomas MedGen